NASDAQ$AKYA

Akoya Biosciences Inc · Q2 2025 earnings

Q2 2025 earnings · · After market close · Investor relations

Reports awaiting report

Akoya hasn't published Q2 2025 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.

  • Most recent report

    Q1 2025

    Revenue
    $16.6M
    EPS
    -$0.32
  • Year-ago · Q2 2024

    Q2 2024

    Revenue
    $23.2M
    EPS
    -$0.27
  • FY2025 consensus

    Analyst consensus

    Revenue
    $91.6M
    EPS
    -$0.62

Revenue & EPS history

Akoya · Revenue · Quarterly

$16.6M

Q1 2025-9.3%vs Q1 2024
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Historical revenue by segment

Akoya · $18M total across 1 segment · Q3 2023

  • Product revenue
    $18M+25.3%

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 10 quarterly earnings reports

Historical avg

-3.7%

Avg return

Earnings day

-8.6%

Avg return

5 days after

-17.2%

Avg return

30 days after

53%

10 / 19 earnings

Positive

+13.7%

Q4 2021

Best reaction

-31.9%

Q1 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2025
Q2 2025
Q1 2025+1.0%+24.8%+23.8%
Q4 2025+3.8%+9.2%-30.7%
Q3 2024-24.9%-33.2%-29.5%
Q2 2024-9.5%-0.9%+5.5%
Q1 2024-31.9%-35.1%-50.0%
Q4 2023-15.4%-17.1%-28.1%
Q3 2023+10.0%+6.9%+16.4%
Q2 2023+0.9%-6.5%-23.9%
Q1 2023-2.5%-17.1%-18.8%
Q4 2022-7.3%-17.2%-36.6%
Q3 2022-15.1%
Q2 2022+5.0%
Q1 2022-11.9%
Q4 2021+13.7%
Q3 2020+1.5%
Q3 2021+0.2%
Q2 2021-0.1%
Q4 2020+9.5%
Q1 2021+2.3%
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro